Snipd home pageGet the app
public
JAMA Oncology Author Interviews chevron_right

Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Dec 8, 2022
18:37
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
1
Introduction
00:00 • 3min
chevron_right
2
The Importance of Postoperative Therapy in Pancreatic Cancer
02:47 • 2min
chevron_right
3
The Differences Between General Surgeons and Eye Volume Centers in Pancreatic Cancer Surgery
05:13 • 2min
chevron_right
4
The Role of Adjuvant Treatment in Pancreatic Cancer
07:35 • 3min
chevron_right
5
Adjuvant Therapy for Optimizing Disease Status
10:48 • 2min
chevron_right
6
The Value of Circulating Tumor DNA in the Perioperative Setting in Pancreatic Cancer
12:53 • 2min
chevron_right
7
The Importance of Prospective Randomized Trials
15:17 • 3min
chevron_right

Interview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD. Related Content:

  • Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
HomeTop podcastsPopular guestsTop books